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Antimicrobial removal on piglets 
promotes health and higher 
bacterial diversity in the nasal 
microbiota
Florencia Correa-Fiz  1, José Maurício Gonçalves dos santos  2, Francesc Illas3 & 
Virginia Aragon1
the view on antimicrobials has dramatically changed due to the increased knowledge on the 
importance of microbiota composition in different body parts. Antimicrobials can no longer be 
considered only beneficial, but also potentially deleterious for favourable bacterial populations. Still, 
the use of metaphylactic antimicrobial treatment at early stages of life is a practice in use in porcine 
production. Many reports have shown that antibiotics can critically affect the gut microbiota, however 
the effect of perinatal antimicrobial treatment on the nasal microbiota has not been explored yet. To 
gain insights on the potential changes in nasal microbial composition due to antimicrobial treatments, 
piglets from two different farms were sampled at weaning. The nasal microbiota was analysed when 
antimicrobial treatment was used early in life, and later, when no antimicrobial treatment was used 
during the lactation period. Removal of perinatal antimicrobials resulted in an increased bacterial 
diversity in nasal microbiota at weaning. Concurrently, elimination of antimicrobials produced an 
increase in the relative abundance of Prevotella and Lactobacillus, and a decrease in Moraxella and 
Bergeyella. These changes in microbiota composition were accompanied by an improvement of the 
piglets’ health and a higher productivity in the nursery phase.
The use of antimicrobials to control bacterial diseases is a common practice in porcine production. Despite the 
undeniable fact that usage of antimicrobials plays a vital role in the production of food-animals and in protection 
of public health1, they have proved to negatively affect the beneficial microbiota2. The microbiota is a key factor 
for the well function and homeostasis of different body systems in animals. Key functions of the microbiota 
include the correct development of the immune system and resistance against pathogens colonization or patho-
genicity reduction3–5. The interest on animal microbiota has increased in recent years due to its impact in health. 
Knowledge on microbiota composition can result in the identification of potential bacterial groups associated 
with health5–7, although many factors can interfere in the establishment of a so-called adequate microbiota, such 
as environment, pig production system, pig genetics and antimicrobial treatments8. Microbial dysbiosis, which 
may appear secondarily to antimicrobial use, can facilitate pathogen infections and enhance the tissue damage 
inflicted by pathogenic bacteria9. The use of metaphylactic antimicrobials, especially early in life, can have a 
deleterious impact in animal health through the alteration of the gastrointestinal tract (GIT) microbiota compo-
sition10. Many efforts have been made to elucidate the GIT microbiota composition and the relationship of dys-
biosis with many diseases, however, there is scarce knowledge on the nasal microbiota composition in animals. 
In pigs, it has been demonstrated that the microbial communities inhabiting the nasal cavities at weaning may 
influence the development of Glässer’s disease later in life6 and perinatal antimicrobials are sometimes used to 
reduce the risk of this disease. However, whether the antibiotic treatment early in life has an effect on the bacterial 
communities from the piglet’s nose, has not been explored yet. Here, we analysed the nasal microbiota compo-
sition of 3–4 week old piglets at weaning regarding antimicrobial administration in the lactation phase, with the 
aim of detecting the effect on the microbiota compositions and the association with health status later in life.
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Results
Diversity and species richness from the nasal microbiota. With the aim of analysing the effect of 
perinatal antibiotic treatment on the nasal microbiota composition, 3–4 week old piglets from two farms (MT and 
MC farms) from Spain were sampled. Nasal swabs were taken when both farms were using perinatal antimicrobial 
treatments (MC1 and MT1), and total DNA was extracted and subjected to individual massive sequencing. The 
same sampling was repeated one productive cycle after elimination of perinatal antibiotics in both farms (MC2 and 
MT2). We obtained a total of 8,883,783 joint reads after filtering for both farms (MC1: 876,010; MC2: 3,178,022; 
MT1: 2,533,426; MT2: 2,296,325). The OTUs were identified in the samples that passed the quality-based filters 
(MT1, n = 7; MT2, n = 8; MC1, n = 8; MC2, n = 11) through clustering sequences at 97% sequence homology. At 
phylum level, 98.2% of the sequences were assigned to 7 phyla, while 93% of the sequences were assigned at family 
level, to 41 families. At genus level, 75.5% of the reads were assigned to 68 genera. The relative abundance of the 
OTUs found at genus level in the nasal microbiota is represented in Fig. 1 (for the full list of OTUs assigned at gen-
era level, please refer to Additional File 1; see also Additional File 2 for other taxonomical levels).
One cycle after elimination of perinatal antimicrobials, nasal microbiota of all the weaning piglets analysed 
showed a significant increase in bacterial diversity, as indicated by the analysis of alpha diversity through Shannon 
diversity index (P = 0.002). When farms MC and MT were analysed individually (Fig. 1), this increase in alpha 
diversity was also observed, showing to be statistically significant through non-parametric two-sample t-test (999 
permutations, P ≤ 0.05) only in farm MT (Fig. 1A,B). The mean of observed OTUs richness was also measured 
in rarefied samples at maximum depth (40,000) at the two sampling times in both farms, with means values of 
1,465 (MC1) and 2,237 (MC2) OTUs for MC farm, and 1,221 (MT1) and 4,619 (MT2) OTUs for MT farm. The 
most predominant bacterial genera across all the samples at first sampling time was Moraxella for both farms 
(34.22 ± 6.30% for MT1 and 34.02 ± 5.79% for MC1, Fig. 1C,D) followed by Bergeyella (23.27 ± 3.6% for MT1 
and 8.21 ± 0.7% for MC1, Fig. 1C,D), while the most abundant genera after antimicrobial elimination in both 
farms changed to Prevotella (14.06 ± 4.46% for MT2 and 16.81 ± 3.26% for MC2).
Analysis of the beta diversity both before and after elimination of antimicrobials, showed remarkable dif-
ferences in the bacterial population of the nasal microbiota (Fig. 2). Antimicrobial treatment explained 22.63% 
of the differences observed (P = 0.001). The five most abundant genera explaining the divergence between the 
nasal microbiota before and after elimination of perinatal antimicrobials were: Prevotella, Moraxella, Bergeyella, 
Haemophilus and Mycoplasma (Fig. 2). When the beta diversity was analysed in each farm individually, significant 
differences were observed after elimination of the antimicrobial treatment in both farms (adonis, R2 = 0.2186, 
P = 0.001 for MC and R2 = 0.1935, P = 0.005 for MT). Elimination of antimicrobials caused significant changes 
in the relative abundance of several genera. Among others, Lactobacillus, Phascolarctobacterium, Megasphaera, 
Roseburia and Campylobacter were increased in both farms. The mean of the relative abundance of the Prevotella 
genus increased also after elimination of the antimicrobials, but this increase was only statistically significant for 
MC farm (Table 1). On the contrary, the relative abundance of Moraxella and Bergeyella significantly decreased, 
Figure 1. Nasal microbiota of piglets from farms MT and MC before (1) and after (2) antimicrobial treatment 
removal. Microbiota rarefaction curve generated using Shannon diversity estimator with samples from farms 
MT (A) and MC (B). Samples have been rarefied at an even depth of 40,000 sequences per sample. Error bars 
indicate the 95% confidence intervals. The mean relative abundance (%) of OTUs found in nasal swabs of piglets 
from farms MT (C) and MC (D) is presented at genera level.
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while Haemophilus and Mycoplasma showed a decreased tendency when antimicrobials were removed in farm 
MT, but increased in farm MC (Table 1). Finally, the relative abundance of Neisseria decreased after removal of 
antimicrobials, showing to be significant in MC farm (Table 1).
Stability of microbiota composition after antimicrobial elimination. In order to evaluate the sta-
bility of these changes in the nasal microbiota composition, a third sampling was performed in farm MT (MT3). 
In this run, we obtained a total of 4,003,077 joint reads after filtering (MT3, n = 12). Analysis of alpha diver-
sity showed no further increase in diversity after additional time without perinatal antimicrobials in the farm 
(Fig. 3A, for a full list of OTUs assigned at genera level, please see Additional File 3). However, the samples after 5 
cycles without antimicrobials showed a more similar composition demonstrated with the lower P value obtained 
through the comparison (Fig. 3A; Shannon index, P = 0.003). Besides, the beta diversity analysis, showed a dis-
tinct clustering at the three sampling times tested (Fig. 3B, adonis R2 = 0.15643, P < 0.001). Sixteen genera were 
involved in the long-term changes observed after elimination of the antimicrobials (Table 2 and Fig. 3C). Nine of 
these genera were increased at the third sampling point after 5 productive cycles without antimicrobials, such as 
Faecaliabacterium and Bacteroides.
Health and production parameters in the nursery phase. Concomitantly to the increase in micro-
biota diversity, the MT farm experienced an improvement of health and productivity. Analysis of production 
parameters in the nursery phase from 2015 to 2017, indicated that the elimination of antimicrobial treatments 
resulted in a significant reduction in medication cost by pig and mortality rate, while the reduction observed in 
feed conversion ratio (FCR) was not statistically significant (P = 0.110) (Table 3). In farm MC, the FCR (P = 0.261) 
did not show a clear improvement, but the mortality rate (P = 0.130) and especially the cost in medication per pig 
(P = 0.05) decreased during the study period.
Discussion
The effect of perinatal antimicrobial treatments in the gut microbiota of piglets has been already documented11,12, 
but less information is available on the effect of these treatments on the respiratory tract microbiota. In our study, 
elimination of perinatal antimicrobials resulted in an increase in nasal microbiota diversity, which was accom-
panied by a general health improvement in the piglets. This observation is in agreement with previous reports 
showing an association between health and microbiota diversity10,13. Although not addressed here, another addi-
tional benefit expected after elimination of metaphylactic antimicrobial treatments, would be the reduction in 
the abundance of resistance genes, as reported in the pig GIT microbiome10. Worth to mention is that a more 
similar microbiota composition among the individuals was found in the piglets after 5 cycles without using 
antimicrobials, indicating a developed stability in the microbiota composition. On the contrary, dissimilarity 
in microbiota composition within groups has been considered a measurement of gut dysbiosis associated with 
poor health status14. Importantly, a lower relative abundance of several potentially pathogenic bacteria in the 
nasal microbiota was also demonstrated, while beneficial bacteria were more abundant in both farms when no 
perinatal antimicrobial treatment was applied. Our results agree with those reported by Janczyk et al. (2007) for 
the impact of amoxicillin on the intestinal microbiota of piglets12. Higher relative abundance of potential path-
ogens and a reduction of beneficial bacteria, such as Lactobacillus, was observed when long-lasting amoxicillin 
was administered to piglets, although no direct connection with health status was reported12. Recently, the effect 
of antimicrobial administration was evaluated in older pigs (8 week old) under experimental conditions, where 
no differences were found on bacterial diversity15. Apparent incongruences with that study could be explained 
considering the age of the animals, as it was reported that the nasal microbiota reaches stability 2–3 weeks after 
Figure 2. Principal Component Plots (jackknifed) representing beta diversity on rarefied samples. Beta 
diversity of nasal samples of piglets was computed through unweighted UniFrac analysis for both farms, MT 
and MC, in two different sampling times, before (1) and after (2) elimination of perinatal antibiotic treatment. 
The biplot shows grey spheres corresponding to the five most abundant genera visualized in the PCA space. The 
size of the spheres is proportional to their relative abundance across all the samples.
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weaning16. Thus, the effect of antimicrobial treatment is not expected to be the same in adult animals with an 
established nasal microbiota, than in new-born piglets where the microbiota composition is still developing and 
can be more easily influenced.
Under farm conditions, the use of perinatal antimicrobials has been reported to be detrimental to the health 
of piglets, which may be linked to the higher abundance of potential pathogens17. Although we cannot rule out 
that a reduced diversity caused a poorer development of the immune system11, the healthier condition observed 
in the present study can be associated to the decreased colonization of the upper respiratory tract by potential 
pathogens, which may be farm specific in some cases (e.g., Mycoplasma or Haemophilus). Nasal colonization of 
piglets by Mycoplasma hyopneumoniae at weaning has been associated to a higher risk of disease development in 
growing pigs18. Additionally, M. hyopneumoniae plays a role in the porcine respiratory disease complex and has 
been associated to increase disease severity19. Some potential pathogens, such as Haemophilus parasuis, are highly 
heterogeneous, and while the presence of virulent strains in the nasal cavity of piglets can be considered a risk 
factor for disease development, the presence of non-virulent strains could confer protection against disease20. In 
other cases, the role of a genus in disease is less clear. The genus Moraxella is highly abundant in the nasal micro-
biota of healthy pigs6, but some Moraxella species have been isolated from systemic lesions, indicating that they 
OTU
Relative abundance (%)
MT1 MT2 P value MC1 MC2 P value
Acinetobacter 1.090 0.835 0.132 <1 <1 NA
Actinobacillus 0.837 1.123 0.728 <1 <1 NA
Afipia <1 <1 NA 0.000 1.089 0.001*
Alistipes <1 <1 NA 1.242 0.006 <0.001*
Alloprevotella 0.048 1.902 0.064 0.444 1.635 0.021*
Anaerovibrio 0.011 1.009 0.037* 0.048 1.094 0.010*
Bacteroides <1 <1 NA 1.694 0.366 <0.001*
Barnesiella 0.104 2.001 0.049* 1.172 2.562 0.160
Bergeyella 23.275 4.370 0.003* 8.215 0.009 <0.001*
Bosea <1 <1 NA 0 1.153 <0.001*
Campylobacter 0.007 1.883 0.021* 0.030 2.882 0.001*
Clostridium sensu stricto <1 <1 NA 1.207 0.736 0.039*
Clostridium IV <1 <1 NA 2.473 1.283 0.017*
Clostridium XI <1 <1 NA 1.341 0.723 0.017*
Clostridium XlVa <1 <1 NA 2.416 1.195 0.017*
Escherichia/Shigella 0.100 1.174 0.418 0.528 2.212 0.058*
Faecalibacterium 0.026 1.411 0.011* 0.098 1.633 0.001*
Gemmiger 0.019 1.186 0.015* <1 <1 NA
Haemophilus 13.896 2.927 0.015* 0.905 2.195 0.026*
Klebsiella <1 <1 NA 8.810 0.011 <0.001*
Lachnospiracea_incerta_sedis 0.068 1.233 0.132 0.328 1.089 0.117
Lactobacillus 0.328 3.453 0.004* 1.400 4.406 0.032*
Megasphaera 0.010 2.164 0.008* 0.033 4.971 0.001*
Moraxella 34.220 9.185 0.015* 34.024 3.189 0.001*
Mycoplasma 3.051 0.577 0.011* 6.718 10.324 0.509
Neisseria 5.09 4.26 0.780 1.00 0.02 0.003*
Oscillibacter 0.119 1.426 0.165 1.586 1.483 0.680
Paraprevotella 0.010 1.067 0.028* 0.039 1.131 <0.001*
Phascolarctobacterium 0.043 3.013 0.004* 0.106 4.072 <0.001*
Prevotella 0.364 14.066 0.083 1.319 16.805 0.002*
Psychrobacter 0.276 5.518 0.563 <1 <1 NA
Roseburia 0.020 2.466 0.005* 0.080 1.972 0.001*
Rothia 0.558 1.406 0.817 <1 <1 NA
Selenomonas 0.007 1.113 0.028* <1 <1 NA
Staphylococcus 1.493 0.029 0.002* <1 <1 NA
Streptococcus 1.584 1.028 0.418 1.002 0.982 0.457
Succinivibrio 0.012 1.058 0.037* 0.083 1.706 0.137
Treponema 0.047 2.666 0.105 0.083 3.554 <0.001*
Table 1. Relative abundance of OTUs before and after elimination of antibiotic treatment in two different farms 
(>1% relative abundance). *Significantly different. NA, not available. When the relative abundance was <1% in 
both sampling times, the P value was not estimated. The OTU was included for comparison with the other farm 
that showed higher abundance (>1%).
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have pathogenic potential21–23. Although there is no available confirmation that Bergeyella can be pathogenic to 
pigs, some species has been associated to human septicaemia and endocarditis24. Experimental support to the 
putative pathogenicity of Bergeyella in pigs has been obtained in in vitro studies with nasal isolates from this bac-
terial genus25. The reduction in the abundance of pathogens reported may be the result of direct competition of 
the microbiota against pathogen colonization or indirectly by an improved maturation of the immune system11. 
Either way, the resulting reduction in pathogen load would most probably result in an improved-health status. On 
the other hand, the relative abundance of some potential pathogens was increased, as observed for Campylobacter 
and Treponema. However, the role of these genera in disease needs deeper analysis at species and strain level to 
proper assess their virulence potential. For instance, Campylobacter comprises a high diversity of strains, which 
are becoming apparent by studying Campylobacter populations in different animal species26.
The balance in the composition of the microbiota community needs to be also considered. Thus, while the 
abundance of some pathogenic bacterial genera decreased, the opposite was observed for some of the genera 
linked to beneficial effects on animal health. Besides the well-known probiotic genus Lactobacillus, other poten-
tial beneficial genera were detected in this study, such as Prevotella and Bacteroides. Prevotella has been reported 
previously as a beneficial and/or protective bacteria or at least an important component of healthy microbiota of 
animals and humans27,28. Although some Bacteroides have been considered opportunist pathogens29–31, at least 
one strain within the species Bacteroides fragilis has been identified as a potential probiotic for human health32. In 
general, an in-depth analysis of the specific species and strains is needed to define the specific role of each taxon 
within each genus and its potential role in animal health.
The present study confirms the benefits of the elimination of perinatal antimicrobial usage in the health of pig-
lets, through modulation of the nasal microbiota composition. Based on the long-term results presented herein, 
antimicrobial treatments should be carefully applied especially at early stages in life, when the cross-talk with 
commensal microorganisms will determine the microbiota establishment throughout life.
Figure 3. Stability of the nasal microbiota of piglets from farm MT through three different sampling time-
points. (A) Alpha diversity using Shannon diversity index over rarefied samples is compared before perinatal 
antibiotic elimination (MT1) and after 1 (MT2) or 5 productive cycles (MT3). (B) Beta diversity analysis 
(jackknified principal component analysis) of the nasal microbiota composition among samples collected before 
(MT1) and after 1 (MT2) or 5 productive cycles (MT3) antimicrobial treatment removal. The two principal axis 
are shown with the percentage of variation explained between brackets. (C) The mean relative abundance (%) 
at genera level for farm MT after 5 productive cycles without using perinatal antibiotic treatment. Color-coding 
for each representative OTU are the same that in Fig. 1.
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Material and Methods
Farms and sampling. Nasal swabs from 3–4 week old piglets were collected at different time points, from 
two different farms (MT and MC) located in the area of Catalonia, Spain. First sampling was done on May-June 
2015 when both farms were using perinatal antimicrobial treatments, labelled as MT1 and MC1, for MT and 
MC farms respectively. MT farm used penicillin and streptomycin at 3 days after birth and tulatromycin one 
week later; while MC farm used ceftiofur at 3 days and tulatromycin one week later. A second sampling was 
done after one farrowing interval without usage of any perinatal antimicrobial treatment, in October-November 
2015, labelled as MT2 and MC2. In MT farm, a third sampling was performed in March 2017 (labelled as MT3). 
The MT farm was a 3300-sows multi-site pig production system and MC farm was a 480-sows farrow-to-finish 
production system. MC farm was negative to porcine reproductive and respiratory syndrome virus (PRRSV) 
OTU Relative abundance MT3 (%) MT1 vs MT3 P value MT2 vs MT3 P value
Acinetobacter 0.013# 0.002* NA
Actinobacillus 0.521# NA 0.482
Alistipes 2.043 0.002* <0.001*
Alloprevotella 0.222# NA 0.354
Anaerovibrio 0.044# NA 0.165
Bacteroides 15.104 0.002* <0.001*
Barnesiella 0.895# NA 0.354
Bergeyella 15.109 0.09 0.011*
Campylobacter 0.023# NA 0.105
Clostridium sensu stricto 1.452 0.527 0.217
Clostridium XlVa 2.064 0.002* 0.007*
Escherichia/Shigella 0.431# NA 0.938
Faecalibacterium 2.903 0.002* 0.017*
Gemmiger 0.479# NA 0.354
Haemophilus 6.954 0.343 0.031*
Lachnospiracea_incertae_sedis 1.665 0.002* 0.217
Lactobacillus 1.751 0.008* 0.076
Megasphaera 0.130# NA 0.076
Moraxella 12.308 0.015* 0.189
Mycoplasma 0.086# 0.002* NA
Oscillibacter 1.067 0.002* 0.487
Parabacteroides 1.386 0.002* <0.001*
Paraprevotella 0.301# NA 0.354
Phascolarctobacterium 0.733# NA 0.354
Prevotella 4.347 0.002* 0.354
Psychrobacter 0.027# NA 0.537
Roseburia 1.181 0.002* 0.938
Rothia 1.838 0.002* 0.105
Selenomonas 0.009# NA 0.013*
Staphylococcus 0.037# 0.002* NA
Streptococcus 1.023 0.035* 0.354
Succinivibrio 0.029# NA 0.105
Treponema 0.074# NA 0.142
Table 2. Relative abundance of OTUs at third sampling time in MT farm compared with the previous 
samplings. *Significantly different. #The OTU is included in the list although having relative abundance less 
than 1% for comparison with previous samplings. NA, not available. When OTUs appeared at less than 1% of 
relative abundance in both sampling times, the P value was not estimated.
MT
P value*
MC
P value*2015 2016 2017 2015 2016 2017
Medication cost (€/pig) 0.870 0.543 0.515 0.037 0.843 0.478 0.390 0.050
Mortality rate (%) 5.46 3.24 3.19 0.050 2.83 3.05 2.58 0.130
Feed conversion ratio 1.659 1.487 1.477 0.110 1.675 1.471 1.559 0.261
Table 3. Production data collected from the nursery phases of MT and MC farms in three consecutive years. *P 
values were estimated through Krukal-Wallis non-parametric test.
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while MT was PRRS-positive, although no circulation of the virus was diagnosed throughout the study. All the 
animals were vaccinated against porcine circovirus type 2 (PCV2) and Mycoplasma hyopneumoniae. During the 
study period no other management practices were modified in any farm, except for the antibiotic treatment 
elimination. Production data were collected during the period of the study. Collection of nasal swabs (sterile with 
aluminium handle) was done one day prior weaning from both nostrils (5–6 cm depth) using the same swab. 
The swabs were kept refrigerated until arrival within 24 hours to the laboratory, where they were stored in PBS 
(0.5 mL) at −20 °C.
Sampling of piglets was done under institutional authorization and followed good veterinary practices. 
According to European (Directive 2010/63/EU of the European Parliament and of the Council of 22 September 
2010 on the protection of animals used for scientific purposes) and Spanish (Real Decreto 53/2013) normative, 
this procedure did not require specific approval by an Ethical Committee. Nasal sampling was performed only 
once to each piglet and is not likely to cause pain, suffering, distress or lasting harm equivalent to, or higher than, 
that caused by the introduction of a needle in accordance with good veterinary practice (Chapter I, Article 1, 5 
(f) of 2010/63/EU).
DNA extraction and sequencing. Total genomic DNA was extracted using Machinery Nigel Kit (GmbH 
& Co, Düren; Germany), following manufacter’s instructions and resuspended in 50 µl of elution buffer. Quality 
and quantity was evaluated on a BioDrop DUO (BioDrop Ltd, Cambridge. UK). The library preparation for 
sequencing was performed within 24 h after the DNA extraction at Servei de Genòmica, Universitat Autònoma de 
Barcelona. Sequencing of the V3-V4 region of 16S rDNA gene was done with Illumina MiSeq pair-end 2 × 250 bp 
technology following the manufacturer instructions (MS-102–2003 MiSeq® Reagent Kit v2, 500 cycle). The 
region targeted to perform the 16S amplification was the one spanning the V3 and V4 region of 16S rRNA gene 
selected from Klindworth et al.33. Interest-specific primers targeting this region were the ones recommended by 
Illumina with overhang adapters attached:
16S Forward Primer 5′ TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG
16S Reverse Primer 5′ GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC.
Cycling conditions were the same reported previously6. The PCR products were purified and checked to verify 
its size on a Bioanalyzer DNA 1000 chip (Agilent).
Read filtering and data analysis. For the taxonomic analysis, reads were quality-filtered (Q > 25) before 
paired-end joining by QIIME v1.9 software34, using fastq join35,36 under default values. Sequences were clustered 
into OTUs at 97% similarity using UCLUST algorithm37 and the Greengenes database38. Chimeric detection 
and removal was done with USEARCH 6.137,39 against the ChimeraSlayer reference database40. To minimize the 
inflation of rare OTUs in the community analysis, we also exclude singletons for further processing. Taxonomic 
assignment was done Naïve Bayes classification against RDP database41. For each taxon, the Kruskal Wallis test 
was perform to compare OTU frequencies in sample groups and to ascertain whether or not there are statistically 
significant differences between the OTU abundance in the different sample groups, P values were FDR-corrected 
for multiple hypotheses testing. Single rarefaction, based on the sample with the lowest number of reads, was used 
for alpha-diversity analysis. Diversity indexes were calculated on rarefied 16S rRNA gene sequence data for all 
samples at 97% similarity. Alpha diversity between groups was compared through two-sample non-parametric 
t-tests (Monte Carlo method) at maximum depth in rarefied samples (with 999 permutations). In addition, equal 
number of samples was subsampled to assess the significant differences between sample types using UniFrac 
weighted and unweighted distances42,43. The percentage of variation between grouped samples was measured by 
R2, using adonis function of the vegan package44 in R software. Estimation of P values was done through Monte 
Carlo test with 999 random permutations of the data set. Preliminarily, combined data from both farms were 
compared before and after antimicrobial treatment elimination to explore the data. However, each farm was ana-
lysed separately at the different time points throughout all the study. Samples were considered to be significantly 
different when the accompanying P value was ≤0.05. Results were confirmed with SAS software through PROC 
GLM analysis.
The production data parameters were statistically analysed through Krukal-Wallis non-parametric test using 
R software45.
Data Availability
The entire sequence dataset is available at the NCBI database, SRA accession PRJNA495126.
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